Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease

INTRODUCTION: Parkinson’s disease (PD) is a chronic and progressive neurodegenerative condition due to the degeneration of nigral dopaminergic cells. Both motor and non-motor symptoms (NMS) of PD produce a marked impairment in PD patients’ quality of life (QoL), but contrary to motor features, NMS d...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinoza-Vinces, Christian, Villino-Rodríguez, Rafael, Atorrasagasti-Villar, Ainhoa, Martí-Andrés, Gloria, Luquin, María-Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576461/
https://www.ncbi.nlm.nih.gov/pubmed/37840836
http://dx.doi.org/10.2147/PROM.S369590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576461/
https://www.ncbi.nlm.nih.gov/pubmed/37840836
http://dx.doi.org/10.2147/PROM.S369590

Ejemplares similares